Importance Most older patients with esophageal cancer cannot complete the standard
concurrent chemoradiotherapy (CCRT). An effective and tolerable chemoradiotherapy …

PURPOSE: Optimal management of elderly patients with nonmetastatic esophageal cancer
is unclear. Patterns of care and long-term outcome data after locoregional treatment …

Purpose The optimal treatment approach for patients≥ 80 years (“elderly”) with esophageal
cancer is not well established. We assessed the clinical outcomes in elderly patients treated …

Objective: The efficacy and safety of definitive chemoradiotherapy (CRT) for elderly patients
with esophageal cancer have not been fully elucidated yet. We conducted a retrospective …

Randomized trials of chemoradiation for esophageal cancer have included very few patients
age≥ 75. In this retrospective study, we describe the outcomes and toxicity of full-dose …

Background Concurrent chemoradiotherapy is a standard treatment for local advanced
esophageal cancer, but the outcomes are controversial. Our goals were to compare the …

How best to manage advanced esophageal cancer remains unresolved, especially in
palliative care. Here, in a pilot study, we evaluated the efficacy and safety of concurrent …

Objectives Large numbers of elderly patients in the USA receive no treatment for
esophageal cancer, despite evidence that multimodality treatment can increase survival. Our …

To investigate the efficacy and toxicity of definitive chemoradiotherapy (CRT) for elderly
patients with locally advanced esophageal cancer. Twenty-two patients aged over 75 that …

Purpose/Objective (s) Increasing dose of chemoradiotherapy in locally advanced
esophageal cancer unsuitable for surgery has been a matter of debate in the last 2 decades …